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The building of the vessel wall from its cellular and extracellular matrix (ECM) components is a critical event in the
development and maturation of the cardiovascular system. However, little is known about the events that occur after the
initial vascular network, a nascent endothelium, is established. The proper recruitment of vascular smooth muscle cells
(VSMCs) to the endothelium is one such critical event. Although the majority of VSMCs are of mesodermal origin, it is
not understood which populations of embryonic cells are capable of following the VSMC differentiation pathway. Previous
studies, which have focused on the VSMC component of vessel wall development, have been limited by the use of markers
that are not smooth muscle speci®c, or have focused on events that occur after a multilayered wall has been established.
Therefore, the initial goal of this study was to de®ne when overtly identi®able VSMCs were ®rst associated with the
vascular endothelium. Monoclonal antibodies (MAbs) were generated from embryonic vessel wall antigens in order to
circumvent problems of cell speci®city associated with the use of previously available markers to VSMCs. Critical to this
study is our MAb, 1E12, which unlike other antibody markers, is smooth muscle speci®c. Using 1E12, we de®ned a pattern
for recruitment and differentiation of the VSMC component of the descending aorta in stage 12 to stage 20 (Hamburger
and Hamilton, 1951) quail embryos. Immuno¯uorescent labeling of quail embryos with 1E12 and a MAb to smooth muscle
a-actin (SMaA) shows that the ®rst mesodermally derived cells to associate with the aortic endothelium do so at the
ventral surface. Recruitment of these cells, which we believe to be primordial VSMCs, proceeds in a ventral to dorsal
direction along the aorta and in a radial direction, emanating from the endothelium. Additionally, we have determined
the distribution of several ECM proteins, during the initial events of vessel wall development. Our studies show that
®bulin-1 is expressed surrounding the primordial VSMCs of the vessel wall before elastin precursors are present and suggest
that differential expression of the JB3 antigen (Wunsch et al., 1994) may be indicative of early diversity among embryonic
VSMCs. q 1996 Academic Press, Inc.
INTRODUCTION 1991; and for a recent review of the VSMC see Schwartz
and Mecham, 1995). Although it is clear that VSMCs are
The formation and maintenance of the vascular system integral to understanding vascular development and homeo-
is essential for vertebrate development, maturation, and ho- stasis, little is known about the recruitment of VSMC pro-
meostasis. The process begins with the formation of nascent genitors and the subsequent differentiation program these
endothelial tubes by means of vasculogenesis and/or angio- cells undergo. The majority of VSMCs are of mesodermal
genesis (Cof®n and Poole, 1988; Poole and Cof®n, 1989; origin, but unlike other mesodermal precursor cell popula-
Pardanaud et al., 1989). The next event during vascular de- tions (including skeletal and cardiac muscle cells), a discrete
velopment is the proper recruitment of vascular smooth population of VSM progenitor cells cannot be distinguished
muscle cells (VSMCs) to the nascent endothelium. Both in the developing organism. (A subpopulation of neural crest
the synthetic and contractile functions of the embryonic cells contributes to the smooth muscle layers of the out¯ow
VSMCs are critical for the establishment of a physiologi- tract and aortic arches, as well as portions of the heart.) (See
Le Lievre and Le Douarin, 1975; Kirby, 1988; and Kirby andcally mature vessel (Berne and Levy, 1988; Mecham et al.,
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Waldo, 1995, for discussion of neural crest derived VSMCs.) located on either side of the midline, in a cranial to caudal
direction as development proceeds, which makes this anThus, it is not understood whether there are mesodermal
subpopulations destined to become VSMCs or whether lo- ideal system for studying the vessel wall, as several distinct
developmental events can be observed within a single em-cal epigenic factors bias competent cells toward a vascular
smooth muscle lineage. bryo.
A series of monoclonal antibodies (MAbs) to embryonicCentral to studying VSMC determination and differenti-
ation is understanding the coordinated temporal expres- vessel wall antigens was constructed, based on the hypothe-
sis that mesodermal precursor cells express novel proteinssion and regulation of VSMC genes (Owens, 1995). A criti-
cal question is to determine when, during vessel wall for- as they become committed to the VSMC lineage and that
MAbs would be a method of identifying such markers. Onemation, VSMCs are ®rst recruited to nascent endothelial
tubes and become overtly identi®able as VSMCs, based on of these MAbs, 1E12, was critical to the present study of
vessel wall development. The 1E12 MAb labels smoothexpression of marker proteins. The two major limitations
for answering this question have been: (1) most of the muscle in both embryonic and adult tissues, including vis-
ceral organs. We have used 1E12 in conjunction with a MAbmarkers studied are not smooth muscle speci®c and (2)
previous studies have focused on relatively late develop- to SMaA to de®ne the cellular and morphological pattern
of VSMC recruitment and differentiation.mental stages, after a multilayered vessel wall already has
been established. The most commonly used marker for We have also examined the distribution of several ECM
proteins during the initial events of vessel wall develop-VSMCs is smooth muscle a-actin (SMaA) (Gabbiani et al.,
1981; Fatigati and Murphy, 1984; Owens and Thompson, ment, because regulation of expression of ECM proteins by
developing VSMCs is often overlooked in relation to other1986). Unfortunately SMaA is expressed in multiple em-
bryonic cell types, including cardiac and skeletal myo- VSMC proteins. Recently, ECM micro®brillar and micro®-
brillar associated proteins (for example ®brillin, ®bulin 1blasts, as well as primordial smooth muscle cells (Skalli
et al., 1986; Glukhova et al., 1988; Ruzicka and Schwartz, and 2, and the JB3 antigen, a putative avian ®brillin) have
been implicated in development of the cardiovascular sys-1988; Sawtell and Lessard, 1989; de Ruiter et al., 1990;
Sugi and Lough, 1992). Therefore, SMaA expression alone tem (Spence et al., 1992; Zhang et al., 1993; Gallagher et
al., 1993; Wunsch et al., 1994; Zhang et al., 1994, 1996;is not diagnostic for identi®cation of primordial VSMCs.
A recent report by Duband and co-workers (1993) suggests Bouchey et al., 1996). Although the function of these pro-
teins during development is not well understood, our stud-the use of the smooth muscle proteins calponin and SM22
as ``differentiation markers'' for smooth muscle. However, ies suggest that expression of ®bulin-1 may be an early
marker for differentiating VSMCs, while the expression pat-these markers appear relatively late in the course of vessel
wall development (avian Embryonic Day 4 and Day 6 for tern of the JB3 antigen may be indicative of the diversity
within the VSMC developmental program.SM22 and calponin, respectively); also, both calponin and
SM22, like SMaA, are expressed in non-smooth muscle
cells during development (Li et al., 1996; Samaha et al.,
1996; Miano and Olson, 1996). Miano et al. (1995) have MATERIALS AND METHODS
shown by in situ hybridization and RNase protection stud-
ies that expression of the smooth muscle myosin heavy Hybridoma Production
chain (MHC) isoforms, MHC-1 and MHC-2, is restricted to
Four 6- to 8-week-old female Balb-c mice were immunized subcu-smooth muscle cells at 10.5 days postcoitum in embryonic
taneously with a crude homogenate of 10-day-old embryonic quailmice. Although MHC transcripts are the ®rst reported tis-
dorsal aorta (two aortae per mouse per injection) in Freund's com-sue speci®c markers for smooth muscle cells, they also are
plete adjuvant (Sigma) and boosted twice at 14-day intervals withexpressed after the initial, critical stages of vessel wall
homogenized aortae (same as above) in Freund's incomplete adju-
formation have occurred. In addition to the lack of appro- vant (Sigma). Ten days after the last injection, tailbleeds were per-
priate markers, the fact that a number of different organ- formed, and the serum activity was assessed via immuno¯uores-
isms and in vitro experimental systems have been utilized cence microscopy of 5-day-old embryonic quail cross sections. Mice
to study VSMCs makes a comprehensive understanding of producing antibodies directed against the embryonic quail vascula-
ture were chosen as spleen donors for fusion with myeloma cells.smooth muscle differentiation dif®cult. For example, there
A total of four lymphocyte±myeloma fusions were performed.are no available data on the speci®city of MHC expression
Fusions were performed in the standard manner by the Univer-during avian development.
sity of Virginia Lymphocyte Culture Center (Chapman et al., 1984).In contrast, the present study focuses on the events of
The only modi®cation to this protocol being that the base mediavessel wall development that take place immediately after
in which the hybridomas were prepared and maintained was Iscov'sthe establishment of a nascent endothelial vascular net-
modi®ed DMEM (Gibco-BRL) supplemented with 10% fetal bovine
work. As a model system for studying vessel wall formation, serum (Hyclone; Ogden, UT), 0.06 mM b-mercatoethanol, and 50
we have used the descending aorta of early staged quail mg/liter gentamicin. Cultures were subsequently maintained in
embryos (Day 2±3). This period was chosen because it is our laboratory and screened 10±15 days postfusion. Wells produc-
an active period of vessel wall morphogenesis. The avian ing hybridomas were screened by immuno¯uorescence microscopy
of 5-day-old embryonic quail cross sections. Positive hybridomasaorta forms from the fusion of two vessels (dorsal aortae),
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were determined to be those which showed speci®c labeling of the For double immuno¯uorescent labeling of 1E12 and SMaA,
cleared sections were incubated simultaneously with both primaryembryonic vasculature. Positive hybridoma cultures were cloned
at least twice and also screened by immuno¯uorescence of 5-day- antibodies. (The 1E12 hybridoma is an IgM producing clone, while
the SMaA MAb is an IgG1.) Sections were washed in multipleold embryonic quail cross sections. Isotyping of monoclonal anti-
bodies was done using an Abstat Isotyping kit (Sangstat Medical changes of PBS and then incubated simultaneously in isotype-spe-
ci®c secondary antibodies. A m-chain-speci®c, ¯uorescein-conju-Corp., Menlo Park, CA).
gated, goat anti-mouse Ab was used to detect 1E12. SMaA was
detected with an Fc-fragment-speci®c, goat anti-mouse, Texas red-
conjugated Ab. Sections were then washed, mounted, and viewedEmbryo Preparation for Paraf®n
as above.and PEGD Sectioning
Japanese quail embryos were collected and staged by the criteria
of Hamburger and Hamilton (1951). Embryos were then ®xed in Immunological Reagents
either Omni®x (Zymed Labs, San Francisco, CA) or methacarn
SMaA monoclonal antibodies were obtained from Sigma (clone(60% methanol, 10% glacial acetic acid, and 30% chloroform) for
1A4, Skalli, 1986) and used diluted (1:200 or 1:400) with PBS. A1±2 hr (Omni®x) or overnight (methacarn). Embryos were subse-
polyclonal antibody to human ®bulin-1 was produced in rabbitsquently dehydrated through a graded series of either ethanol (Om-
and used at a 1:50 dilution. The monoclonal antibody to the JB3ni®x ®xation) or methanol (methacarn ®xation). Fixed, dehydrated
antigen was obtained from Drs. Ann Wunsch (Medical College ofembryos were embedded in either polyethylene glycol 400 distear-
Wisconsin; Milwaukee, WI) and Roger Markwald (Medical Univer-ate (PEGD, Aldrich Chemicals) or paraf®n.
sity of South Carolina; Charleston, SC). JB3 hybridoma supernatantEmbryos were prepared for embedding in PEGD by modi®cations
was used undiluted. The QH1 MAb was obtained from the Develop-of the methods of Steedman (1957) and Spence et al. (1992). The
mental Studies Hybridoma Bank (University of Iowa, Iowa City,in®ltration process was initiated by incubating the dehydrated em-
IA). QH1 hybridoma supernatant was also used undiluted. Both thebryos in a 1:1 solution of absolute ethanol and 100% melted PEGD
1E12 and 9D6 MAbs were used as undiluted hybridoma superna-in a 437C oven. Embryos were further in®ltrated in two changes
tants. All secondary antibodies were purchased from Jackson Im-of 100% melted PEGD at 437C. After in®ltration, embryos were
munoresearch (West Grove, PA) and used at a 15 mg/ml dilution.oriented in embedding molds (Baxter) ®lled with fresh 100% melted
PEGD and allowed to harden at room temperature (RT).
Fixed, dehydrated embryos were prepared for paraf®n embedding
Immuno¯uorescence Controlsby incubation at RT in 100% xylene for 1 hr. Embryos were then
in®ltrated by incubation through a series of xylene:paraf®n (3:1,
Appropriate controls were used for all of the immunolabeling
1:1, 1:3) solutions and two ®nal incubations in 100% paraf®n. All
studies presented in this work. Preimmune (when available) or non-
of the above steps were approximately 6 hr in length and were
immune sera were used as negative controls for the primary anti-
carried out in a 587C oven. Embryos were then oriented in embed-
body. For the hybridomas that we produced, nonimmunoreactive
ding molds (Baxter) ®lled with fresh 100% melted paraf®n.
hybridoma supernatant was used as a control. All secondary anti-
Embryos embedded in either PEGD or paraf®n were sectioned
bodies were controlled by labeling of tissue sections. When a single
on a Spencer (American Optical Co.) microtome set at 7 mm. For
¯uorochrome was utilized for immunolabeling, the ¯uorescent sig-
PEGD sections, ribbons were placed on clean, poly-L-lysine (Sigma,
nal was evaluated for crossover into other wavelengths.
St. Louis, MO)-coated slides. Distilled water was then pipetted un-
derneath the sections to allow for ¯attening and spreading. Slides
were placed on a warmer set at 377C for 5 min and allowed to dry Imagingat room temperature overnight. For paraf®n sections, ribbons were
¯oated on warm water and mounted on clean, uncoated slides. One image (Fig. 1a) was created using digital image processing
Slides were allowed to dry for approximately 45 min on a warmer software. A standard photographic negative was converted to a digi-
set at 407C. tal image ®le using a ¯atbed scanner (UMAX Power Look). The
®le was then imported into an image editing software program
(Adobe Photoshop) and processed using contrast enhancement and
Immunolabeling of PEGD and Paraf®n sharpening ®lters. The resulting high-contrast image (including
speci®c immuno¯uorescence and background auto¯uorescence)Tissue Sections
was rendered as a three-dimensional relief object.
Slides containing PEGD sections were cleared in multiple washes
of warm absolute ethanol and rehydrated in phosphate-buffered
saline (PBS). Slides containing paraf®n sections were cleared in Immunoblot
several washes of 100% xylene, followed by rehydration in a graded
series of ethanol, and a ®nal incubation in PBS. All sections were Chicken gizzards were homogenized in Tris-buffered saline (0.05
M Tris/HCl, pH 7.5, 0.15 M NaCl) and cleared by centrifugationthen blocked in a solution of 3% bovine serum albumin (BSA) in
PBS for 30 min. Immunolabeling of all sections was accomplished as described (Hungerford, 1995; manuscript in preparation). Ali-
quots of the supernatant were mixed with SDS±PAGE samplein the following manner: sections were incubated in primary anti-
bodies for 1 hr, washed in three changes of PBS, followed by incuba- buffer (Laemmli, 1970) and subjected to electrophoresis on 10%
polyacrylamide gels. The fractionated polypeptides were trans-tion in secondary antibodies for 1 hr, and additional washing in
PBS. All sections were then mounted in GelMount (Biomeda, Foster ferred to nitrocellulose membranes (Towbin et al., 1979), blocked
with nonfat milk/PBS, and then incubated with 1E12 antibodies (1City, CA) and viewed on a Leitz DMR photomicroscope using DIC-
Fluotar objectives. hr). It was necessary to incubate the 1E12 IgM in a solution of 0.5%
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SDS for 1 hr at room temperature prior to incubation with the that while SMaA is known to be expressed by primordial
membrane. After washing in PBS the membrane was incubated cardiac muscle cells (Sugi and Lough, 1992; Ruzicka and
with chemiluminescence reagents (ECL blotting kit, Amersham Schwartz, 1988), the 1E12 antigen was never observed in
Life Sciences) and exposed to X-ray ®lm. the developing cardiac muscle (Hungerford, 1995). During
later development, 1E12 is localized in all other smooth
muscle structures (including the vessel wall of both the
RESULTS arterial and venous circulations, as well as all visceral
smooth muscle containing tissues); however, during this
period of development, vascular tissue is the only smoothProduction of the 1E12 MAb
muscle containing structure in the embryo. It appears from
To develop MAbs that could be used to identify VSMCs our data that at these early stages, development of the aortic
at early stages of vascular development, we immunized wall preceeds that of the cardinal veins, such that 1E12 will
mice with crude extracts of embryonic quail vessel wall be expressed by venous smooth muscle cells at later stages
tissue (see Materials and Methods). All of the immunized (data not shown). Therefore, 1E12 de®nes a cell type
mice exhibited robust immunological responses to the em- uniquely associated with endothelium at these early devel-
bryonic quail vascular antigens, as demonstrated by screen- opmental stages.
ing of the post immune sera. Immune sera were immunore-
active with vascular cells of both small and large vessels,
including the descending aorta, and ECM surrounding vas-
Mesodermally Derived Presumptive VSMCscular and nonvascular tissue (data not shown). From the
First Congregate at the Ventral Surfacethousands of hybridoma subcultures screened, one mono-
of the Aortic Endotheliumclonal antibody, 1E12, speci®cally labeled smooth muscle
cells. Figure 1 shows a cross section of a 3.5-day (stage 22; To determine precisely the time and place presumptive
Hamburger and Hamilton, 1951) quail embryo at the level VSMCs become associated with the nascent endothelium,
of the heart atrium, immunolabeled with 1E12. Figure 1a we analyzed serial cross sections of stage 12 to stage 20
is a digitally created 3D relief image of the epi¯uorescence quail embryos using differential interference contrast (DIC)
view shown in Fig. 1b. The 1E12 MAb labels presumptive optics. Figure 3 shows a representative series of cross sec-
smooth muscle cells around the descending aorta (*). The tions through the descending dorsal aorta (aortae) of a stage
primordial muscle cells in the myotome (arrows, Fig. 1) and 15 embryo. In more caudal regions of the embryo (Figs. 3a
myocardium (arrowheads, Fig. 1) are not recognized by 1E12 and 3b) the individual dorsal aortae are in the process of
antibodies. fusing at the midline. There are very few cells associated
with the endothelium, although along the ventral surface
of the aortae (arrowheads) some mesodermal cells appear toThe 1E12 MAb Recognizes Presumptive VSMCs
be adjacent to the endothelium. There are few or no cells
associated with the endothelial layer of the vessel on itsIn order to evaluate the potential use of 1E12 to identify
primordial VSMCs, we compared immuno¯uorescent label- dorsal surface (arrows). The conspicuous absence of cells in
the space surrounding the notochord (x) is noteworthy. Ining of 1E12 with that of a known marker, a SMaA mono-
clonal antibody. During early vessel wall development, the a slightly more cranial cross section of the embryo, Figs. 3c
and 3d, the individual dorsal aortae have completed their1E12 MAb labels a subset of SMaA-positive cells. Figure 2
shows a cross section of a stage 20 (3-day-old) embryo la- fusion at the midline to form a single descending aorta.
Cells at this aortic level have invaded the space ventral tobeled with the both the SMaA MAb (Fig. 2a) and 1E12 (Fig.
2b). The results show SMaA to be expressed in the primor- the notochord (x) and several cells appear to be associated
with the dorsal aspect of the aortic tube (arrows). However,dial skeletal muscle cells of the myotome (arrowheads), as
well as in the cells surrounding the aorta (*). An additional the majority of cells associated with the endothelium, per-
haps VSMC progenitors, remain packed along the ventralgroup of mesodermal cells on the ventral surface of the aorta
also reacted with the SMaA antibody (arrow), as did cells surface of the vessel (arrowheads). Sections prepared from
more cranial levels, Figs. 3e and 3f, show mesodermallypositioned at the medial aspect of the cardinal veins, located
on either side of the aorta (open arrow). derived cells surrounding the aortic endothelial tube (arrow-
heads).In contrast, at stage 20, the 1E12 antigen (Fig. 2b) was
only detected in what appeared to be a subset of the SMaA It is not possible to determine from the preceding images
(Figs. 3a±3f) if the cells most adjacent to the ventral surfacepositive cells surrounding the aorta (*), notably those cells
positioned along the ventral surface of the aortic tube of the aorta are actively engaged in the process of organizing
a de®ned vessel wall structure. However, by Embryonic Day(arrow). The subset of SMaA-positive cells that 1E12 recog-
nizes are those mesodermally derived cells most adjacent 3 (stage 20) an anatomically discrete condensation of cells
is observed around the aortic endothelium (arrowheads, Fig.to the endothelium. The 1E12 antigen is not expressed by
the myotomal cells (arrowheads) or by any cells surrounding 4a). A higher-magni®cation view of the vessel wall at this
stage (Fig. 4c) demonstrates that the aortic wall is now athe cardinal veins (open arrows). It is also important to note
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FIG. 1. The 1E12 Mab, which was produced against embryonic vessel wall antigens, speci®cally recognizes smooth muscle in avian
embryos. The cross-sectional image of a stage 22 (3.5-day) quail embryo shown in a was created from the negative of the corresponding
epi¯uorescent image (b), using digital image processing software. Primordial VSMCs surrounding the descending aorta (*) are immunola-
beled with the 1E12 MAb. The primordial muscle cells in the myotome (arrows), as well as in the atrial myocardium (arrowheads), are
not immunoreactive with 1E12. Nt, neural tube; x, notochord. Magni®cations, (a) 551; (b) 601.
multilayered structure, distinct from the nearby, loosely SMaA MAb is not labeling the endothelial component of
arranged mesenchyme. the nascent vessel. At stage 17 (2.5 days) SMaA expression
was observed in a single layer of mesodermal cells located
between the vascular endothelium and the endoderm in a
The 1E12 Antigen and SMaA De®ne a Ventral to cross section through the dorsal aortae at the level of the
Dorsal, as Well as a Radial, Pattern of VSMC vitelline arteries (Figs. 5c and 5d). SMaA expression is not
Recruitment to the Aortic Endothelium observed in any other intraembryonic mesodermal struc-
tures, although several extraembryonic mesodermal cellsIn order to determine whether the cells that we ®rst ob-
are labeled (arrowhead, Fig. 5c).serve associating with the endothelium express SMaA and
The cross section in Fig. 6a is also immunostained withthe 1E12 antigen, progressively older embryonic stages were
the SMaA MAb. In this region of a stage 15 (2.25-day)examined with immuno¯uorescence microscopy, begin-
embryo the dorsal aortae are located at the midline and thening at stage 12. The ®rst cells to express SMaA in the
endoderm has formed the primitive gut. The majority ofvicinity of the descending aorta are located adjacent to the
SMaA-positive cells are located adjacent to the endothe-endothelium on the ventral surface of stage 12/ (17-somite
lium, particularly on the ventral surface (arrowheads, Fig.or 2-day embryo) dorsal aortae, which are in the process
6a). Interestingly, immunoreactivity was also observedof fusing at the midline (Fig. 5a). In comparison to a serial
within cells situated between the fusing endothelial tubessection immunolabeled with the QH1 MAb (Fig. 5b), a reli-
(arrow, Fig. 6a). Endothelial cells were not labeled with theable marker for the endothelial cell lineage (Pardanaud et
al., 1987; Cof®n and Poole, 1988), it is apparent that the SMaA MAb, as shown in a high-magni®cation view of
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FIG. 2. A cross section from a 3-day quail embryo was double labeled with a MAb to SMaA (a) and 1E12 (b). (a) SMaA is expressed in
the skeletal myoblasts of the myotome (arrowheads) and in the primordial VSMCs surrounding the aorta (*). A group of mesodermal cells
on the ventral surface of the aorta (arrow) are labeled. In addition, the cardinal veins (open arrow) express SMaA on the ventromedial
surface. (b) The 1E12 antigen is expressed in a subset of SMaA positive aortic cells (*), most noticeably in the primordial VSMCs adjacent
to the ventral surface of the endothelium (arrow). 1E12 is not expressed in the myotomal cells (arrowheads) or in the cardinal veins (open
arrows). Magni®cations, (a) 1301; (b) 1301.
SMaA immuno¯uorescence superimposed on a DIC image Expression of the 1E12 antigen is ®rst observed at stage
17±18, approximately 8±12 hr after the onset of SMaA ex-(Fig. 6b). In contrast to the SMaA MAb, 1E12 did not label
the presumptive primordial VSMCs surrounding the endo- pression. Figures 7a and 7b show low- and high-magni®ca-
tion cross-sectional views through a stage 18 embryo in athelium of unfused aortae at these developmental stages
(data not shown). region where the individual dorsal aortae have completely
fused. A layer of mesodermally derived cells immediatelyAs the vessel wall matures, several distinct layers of cells
form, at which time the labeling pattern for the SMaA MAb adjacent to the aortic endothelium stain with 1E12. On the
ventral surface of the vessel 1E12-positive cells are presentbecomes more complex. In the caudal region of a stage 19
quail embryo (Fig. 6c) SMaA expression is detected in the in several layers of the mesoderm surrounding the endothe-
lium (Fig. 7a). A few of these cells appear to be labeled oncells most adjacent to the endothelium; however, an addi-
tional group of SMaA-positive cells are observed ventral to their entire periphery (arrowhead, Fig. 7b). On the lateral
aspect of the vessel 1E12 labeling is observed only in thethe fusing aortae in the midline (arrows). SMaA labeling of
a stage 20 cross section (Fig. 4b) localizes to the layers clos- layer of mesodermal cells adjacent to the endothelium. At
a higher magni®cation the 1E12 labeling appears to be dis-est to the endothelium, corresponding to the condensation
of cells designated by the arrowheads in Fig. 4a. In addition tributed as a thin line of ¯uorescence at the periphery of
the cells, particularly where they appose the basal surfaceSMaA is expressed in a group of cells located ventral to the
aorta (arrow, Fig. 4b) which are not associated with the of the endothelium (arrow, Fig. 7b). Double immunolabel-
ing of similarly staged embryos with 1E12 and the QH1multilayered vessel wall.
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FIG. 3. Analysis of serial cross sections from a stage 15 quail embryo suggests that presumptive VSMCs initially associate with the
ventral surface of the endothelium. (a, b) A representative cross section through a relatively caudal region of the embryo, viewed with
differential interference contrast (DIC) optics. Individual aortae (*) are in the process of fusing at the midline. Few cells are associated
with the endothelium; although along the ventral surface of the aortae (arrowheads), some mesodermal cells are located adjacent to the
endothelium. Above the dorsal aspect of the aortae is a relatively cell free space surrounding the notochord (x). (c, d) The individual aortae
are now fused in a progressively more cranial region of the embryo (*). A few cells have invaded the space surrounding the notochord (x),
and several cells are associated with the aorta on its dorsal surface (arrows). The majority of these presumptive VSMCs are still located
on the ventral surface (arrowheads). (e, f ). Further cranially, the descending aorta (*) is surrounded by presumptive VSMCs (arrowheads).
Magni®cations, (a) 1501; (b) 3001; (c) 1401; (d) 3001; (e) 1601; (f ) 3001.
MAb clearly shows that 1E12 does not label the vascular in the avian embryo, we examined the expression of the
1E12 antigen at multiple morphogenic stages within indi-endothelium (data not shown).
As vessel wall development proceeds, the expression of vidual quail embryos. Figure 8 shows a representative series
of cross-sectional views through the descending aorta of athe 1E12 antigen recapitulates the cranial to caudal and
ventral to dorsal expression pattern that was observed with stage 20 embryo. Figure 8a is the most caudal section of
this series, where the individual aortae are newly fused.SMaA expression. The 1E12 expression pattern also recapit-
ulates the radial pattern of SMaA expression, emanating 1E12 is expressed in only a small population of cells most
adjacent to the ventral aortic endothelium (arrowheads). Infrom the cells that are closest to the endothelium. By ex-
ploiting the progression of cranial to caudal developmental progressively cranial sections, Figs. 8b±8d, an increasing
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FIG. 4. A discrete condensation of mesodermally derived cells, presumably primordial VSMCS (arrowheads), is observed around the
aortic endothelium at stage 20, as shown in this cross section (a) through the descending aorta (*), viewed with DIC optics. The vessel
wall is now a multilayered structure, distinct from the surrounding loosely arranged mesenchyme. (b) Immuno¯uorescent image of the
same vessel as in a, labeled with a SMaA MAb. The expression of SMaA corresponds to the condensation of cells seen in the DIC view
above. However, a group of cells on the ventral surface of the aorta (*), which are not part of the multilayered wall, also express SMaA
(arrow). This image also shows SMaA-positive cells localized to the ventromedial surface of the cardinal veins (open arrows). The DIC
image in c is a higher-magni®cation view of the ventral surface of the descending aorta (*) from a slightly caudal region of the same
embryo as shown above. It is clear form this view that the vessel wall is composed of an endothelium (arrowhead) and one or more layers
of primordial VSMCs (arrows). Magni®cations, (a) 2001; (b) 2001; (c) 3901.
number of 1E12-positive cells are detected in the mesoder- dorsal surface of the aorta and culminates at the ventral
surface. As previously shown in Fig. 2, at this stage of devel-mally derived cells surrounding the ventral surface of the
aorta (arrowheads). In Fig. 8d, the most cranial, and hence opment (stage 20) the cells that express both the 1E12 anti-
gen and SMaA are a subset of the total population of SMaA-most mature, of this series, 1E12-positive cells, are present
as a thin layer over the dorsal surface of the aorta (arrow). positive cells. Furthermore, this subset is composed of those
cells located closest to the endothelial basement mem-Figure 8d also depicts the fact that there is a progressive
increase in 1E12 immunoreactive cells, which begins at the brane.
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The 1E12 Antigen
All embryonic and adult chicken smooth muscle tissues
examined were cross-reactive with 1E12, while rat smooth
muscle tissue was not (data not shown). The 1E12 MAb
was determined to be of the IgM isotype, a pentameric im-
munoglobulin; hence, standard approaches for establishing
an apparent molecular weight of the antigen have been un-
successful. However, by treating the IgM with SDS prior to
immunoblotting, we identi®ed a band (Mr  100,000) from
extracts of adult chicken gizzard that is reproducibly recog-
nized by the 1E12 MAb (arrowhead; Fig. 11). We also observe
a doublet of variably reactive bands at approximately 40
kDa on the SDS±PAGE gels. In some preparations the lower
band of the doublet is stronger than the upper band; in other
instances the doublet is faint (not shown). The crisp band
at 100 kDa is, however, readily detectable. Due to the vari-
ability of the doublet, we are now in the process of generat-
ing a recombinant single-chain antibody, which we hope
will be more suitable for characterization of the 1E12
antigen.
ECM Expression in the Developing Vessel Wall
In addition to cytoskeletal markers, the distribution of
several ECM proteins, ®bulin-1, the JB3 antigen, and ®bro-
nectin (FN), were compared in order to understand better
the role of ECM proteins during smooth muscle maturation.
Fibulin-1 is ®rst expressed in the unfused aortae from a
caudal region of a stage 19 embryo, a time when SMaA-
positive cells are observed only on the ventral surface of
these vessels (arrow, Fig. 9a). At this very early stage of
vessel wall development, ®bulin-1 expression also forms as
a thin layer surrounding cells on the ventral surface of the
aortae (arrows, Figs. 9b). Immunostaining is also detected
FIG. 5. In the region of the embryo surrounding the descending
aorta, SMaA is initially expressed in mesodermal cells located be-
tween the aortic endothelium and the endoderm. (a) SMaA labeling
is observed along the ventral surfaces of the dorsal aortae (arrows)
in the cells closest to the endothelium in a stage 12/ (17-somite)
quail embryo. This is the earliest developmental stage that we
observe SMaA-positive cells in the vicinity of the dorsal aortae (*).
(b) A cross-sectional image adjacent to the image shown in a. This
section is labeled with the QH1 MAb, a reliable marker for the
endothelial cell lineage. A single layer of QH1-positive cells com-
prises the endothelium of the dorsal aortae (*), which are fusing at
the midline. Nonspeci®c labeling is also observed in the ectoderm
(open arrow). (c) This image shows the region where the dorsal
aortae (*) connect with the vitelline arteries (v) in a stage 17 quail
embryo. SMaA labeling is observed primarily on the ventral surface
of the vessels (arrows) and in extraembryonic mesodermal tissue
(arrowhead). A higher-magni®cation image (d) of the left portion of
the vessels in c clearly shows SMaA-positive cells that are located
in a single cell layer between the endoderm (arrow) and endothe-
lium (open arrow). Original magni®cations, (a) 2801; (b) 2801; (c)
1101; (d) 2051.
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FIG. 7. Expression of the 1E12 antigen is ®rst observed in stage
17±18 quail embryos. In this cross-sectional view of a stage 18
quail embryo (a), a thin layer of 1E12-positive cells surrounds the
aorta (*). In a higher-magni®cation view (b) of a lateral wall and
the ventral surface of the aorta 1E12 immuno¯uorescence ®rst ap-
pears as a thin line (arrow) at the periphery of the primordial VSMCs
apposed to the basal surface of the endothelium. A few primordial
VSMCs (arrowhead) on the ventral surface are labeled on their en-
tire periphery. Original magni®cations, (a) 1351; (b) 3901.
surrounding the notochord (x, Fig. 9b). This notocord-asso-
ciated staining should not to be confused with the blood
vessel-associated antigen. A cross section from an adjacent
region of the stage 19 embryo was immunolabeled with aFIG. 6. As the dorsal aortae fuse, SMaA immunolabeling is
MAb to the JB3 antigen. Unlike ®bulin-1 expression, theobserved predominately at the midline on the ventral surface of
JB3 antigen does not appear to be enriched around the pre-the endothelium, as shown in a (arrowheads). SMaA-positive
sumptive VSMCs on the ventral surface of the aortaecells are also observed in the region of endothelial tube fusion
(arrows, Fig. 9c). Instead, the JB3 antigen seems to be ex-(arrow) in this stage 15 quail embryo. (b) A higher-magni®cation
view of the aortae shown in a was viewed with a superimposition pressed by many cell types at this developmental stage,
of immuno¯uorescence and DIC optics. SMaA labels presump- particularly in the region surrounding the notochord (x) and
tive VSMCs on the ventral surface of the aortae (arrowheads). the cells associated with the dorsal aspect of the aortae
The endothelium (arrows) is not labeled. (c) As the vessel wall (arrowheads).
matures, the expression pattern of SMaA becomes more com-
plex. In this image of a stage 19 embryo, the individual aortae
are in the process of fusing at the midline. SMaA expression is
observed in the mesodermal cells most adjacent to the aortic
endothelium. An additional group of SMaA-positive cells, observed in the ventral mesoderm at the midline (arrows). Original
which are not associated with the multilayered vessel wall, are magni®cations, (a) 1601; (b) 3901; (c) 2051.
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FIG. 8. Expression of the 1E12 antigen recapitulates both the ventral to dorsal and radial expression pattern ®rst observed for SMaA.
(a±d) A caudal to cranial series of cross sections through the descending aorta of a single stage 20 embryo, labeled with 1E12. Arrowheads
in each image point to 1E12 expression on the ventral surface of the aorta. In a the most caudal section of this series, only a few cells
express 1E12 on the ventral surface of the fusing aortae. In progressively more cranial sections, b±d, an increasing number of 1E12-positive
cells are observed adjacent to the ventral surface of the endothelium. 1E12 expression is also observed on the dorsal surface of the aorta
in d, the most cranial section of this series (arrow). Magni®cations, (a) 2701; (b) 2001; (c) 2701; (d) 2701.
We also compared ®bulin-1 and JB3 distribution in the onstrate an interesting phenomenon. As shown in Fig. 10,
the expression pattern for the JB3 antigen varies betweendeveloping vessel wall to that of a putative ®bronectin (FN)
variant (Fig. 9d). The 9D6 MAb used in this comparison large and small vessels. Immunolabeling of JB3 (Fig. 10a)
was compared to that of 1E12 (Fig. 10b) in adjacent sectionswas also produced by screening of hybridomas generated
from embryonic vessel wall antigens (see Materials and of the descending aorta. It appears that the presumptive
VSMCs closest to the endothelium, which are 1E12 posi-Methods). Although a comprehensive characterization of
the 9D6 antigen has not been completed, the 9D6 antigen tive, are not associated with the JB3 antigen. In contrast,
smaller peripheral vessels in the body wall of this embryocomigrates with chicken plasma FN on SDS±PAGE and is
recognized by a polyclonal antibody to chicken plasma FN demonstrate a contrasting distribution pattern for these
molecules. In these vessels the JB3 antigen is associatedby immunoblotting techniques (Hungerford, 1995, and data
not shown). Fibronectins are widely distributed in the em- with the endothelium, or the cells most adjacent to the
endothelium (arrows, Fig. 10c), at a time when the 1E12bryo at these early developmental stages; however, 9D6 ap-
pears to preferentially label the ECM surrounding devel- antigen is not expressed in these vessels (Fig. 10d).
oping vessels (Hungerford, 1995). As shown in Fig. 9d, the
9D6 antigen is distributed in the ECM surrounding all as-
pects of the fusing aortae. This image also shows that 9D6 DISCUSSION
is differentially expressed at this stage of development, with
expression decreasing in a ventral to dorsal direction. The establishment of the vessel wall requires the proper
spacial and temporal organization of cellular and connectiveExpression of the JB3 antigen was not observed in a ven-
tral to dorsal pattern around the fusing developing descend- tissue components. While recent research in the ®eld of
vascular biology has focused on the initial formation anding aorta. However, cross sections of stage 22 embryos dem-
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regulation of nascent endothelial tubes, there is little infor-
mation regarding the subsequent steps of VSMC recruit-
ment and differentiation. Numerous studies in many differ-
ent experimental systems have attempted to de®ne the pro-
gram required for VSMC differentiation (reviewed by
Owens, 1995). The ability of a given VSMC to exist along
a continuum of phenotypes has made the regulatory mecha-
nisms of VSMC development and differentiation dif®cult
to study (Thyberg et al., 1990; Owens, 1995). Several recent
reports demonstrate new approaches to understanding the
regulation of smooth muscle differentiation. These include
the use of a retinoic acid-induced clonal cell line that ex-
presses smooth muscle characteristics (Rudnicki et al.,
1990; Blank et al., 1995) and the generation of a loss-of-
function mutation in the Drosophila D-mef2 transcription
factor, which results in embryos that are able to properly
specify and position myoblasts, but do not have differenti-
ated skeletal, cardiac, or visceral smooth muscles (Lilly et
al., 1995). However, fundamental questions regarding the
developmental pathway of VSMCs during the initial events
of commitment and subsequent integration into the vessel
wall remain unanswered.
Our data provide evidence that the initial population of
primordial VSMCs to associate with the endothelium of the
dorsal aortae do so at the ventral surface of the fusing vessel
by stage 12/. Using a novel smooth muscle-speci®c MAb,
1E12, a MAb to SMaA, and a polyclonal antibody to ®bulin-
1, we have de®ned a pattern of VSMC development around
the descending aorta. Embryonic VSMCs develop in both
a ventral to dorsal manner, as well as in a radial pattern
emanating from the layer of cells most adjacent to the endo-
thelium. This model is supported by the observations of
other groups (de Ruiter et al., 1990; Sugi and Lough, 1992;
Duband et al., 1993). While the work of Burke et al. (1994)
describes the ontogeny of vessel wall components of the
out¯ow tract in more advanced developmental stages, this
study is, to date, the ®rst detailed description of a vessel
(the descending aorta) beginning at the stage of a nascent
endothelial tube and ending after a multilayered vessel wall
is established.
cent area of the embryo is localized to the ECM surrounding cellson
the ventral surface of the aortae (arrows). Additional labeling is seen
around the notochord (x). Fibulin-1 is not ubiquitously expressed in
the mesoderm. (c) Unlike ®bulin-1 expression, the JB3 antigen is
not localized around cells on the ventral surface of the fusing aortae
FIG. 9. Primordial VSMCs are versatile cells; they must regulate (arrows). JB3 is expressed in the ECM surrounding many cell types
at this developmental stage, particularly in the region surroundingexpression of both cytoplasmic and extracellular proteins during
the initial stages of vessel wall development. In order to investigate the notochord (x) and dorsal aspect of the aortae (arrowheads). (d)
The 9D6 antigen, a putative FN variant, is preferentially expressedthe role of two recently discovered ECM proteins, ®bulin-1 and the
JB3 antigen, in vascular development, we compared the expression in the ECM surrounding the aortae. It is present in the ECM on
both the dorsal and ventral surfaces of the fusing aortae. However,of these proteins with SMaA and a variant of FN. (a) As shown
previously, SMaA expression is localized to the cells on the ventral it appears that increased staining is present in the ECM of the
ventral aspect of the developing vessel (arrows). x, notochord. Mag-surface of the unfused aortae (arrow) in the caudal region of this
stage 19 embryo. x, notochord. (b) Fibulin-1 expression in an adja- ni®cations, (a) 2401; (b) 2401; (c) 2401; (d) 1801.
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FIG. 10. The expression pattern of the JB3 antigen varies between large and small vessels in stage 22 embryos. The ECM surrounding
the mesodermal layers adjacent to the aortic endothelium do not appear to contain the JB3 antigen (arrows) (a); however, presumptive
VSMCs adjacent to the endothelium are 1E12 positive (arrows) (b). In contrast, the JB3 antigen is a constituent of the ECM adjacent to
the endothelium in small peripheral vessels of the body wall (arrows) (c), while the 1E12 antigen is not expressed in these vessels at this
developmental stage (arrows) (d). Magni®cations, (a) 2601; (b) 2501; (c) 2501; (d) 2701.
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cell fate is a two-step process, involving speci®cation and
determination phases. A cell or tissue is ``speci®ed'' when
it is capable of differentiating autonomously when placed
in a neutral environment, such as in a petri dish. A cell or
tissue is ``determined'' when it is capable of differentiating
autonomously when placed in another region of the embryo.
As these terms are experimentally de®ned, we cannot state
de®nitively where expression of the 1E12 antigen lies along
the VSMC commitment pathway. In addition, it is unclear
whether these terms can be strictly applied to the vascular
smooth muscle cell, given the extensive evidence of the
plasticity of the SMC phenotype and its dependence on
complex environmental cues. From the data presented in
this study, however, we hypothesize that the onset of 1E12
antigen expression designates a de®nable, and critical, step
in commitment to the smooth muscle lineage. Thus, our
results suggest that cells expressing both SMaA and the
1E12 antigen are destined to become VSMC. On the other
hand, SMaA-positive cells, which are not 1E12 immunopos-
itive, represent mesoderm progenitors that are not as ad-
FIG. 11. Chicken gizzard homogenates were subjected to electro- vanced along the VSMC commitment pathway. Regardless
phoresis on 10% SDS±polyacrylamide gels, transferred to nitrocel- of de®nitions, we believe the 1E12 MAb is an excellent
lulose membranes, and incubated with 1E12 antibodies. Immuno- reagent to study the coordinate expression of smooth mus-
reactivity was detected with a chemiluminescence technique. Prior
cle differentiation genes.to incubation with the nitrocellulose membrane, 1E12 was treated
with 0.5% SDS for 1 hr at room temperature. The 1E12 antibodies
detected a strong band at Mr 100,000 (arrowhead) and a variably SMaA and VSMC Origin
reactive doublet at approximately Mr 40,000. In some cases both
bands at 40 kDa were faint. In other cases, unlike the present im- Although it is clear that SMaA expression is not a suf®-
munoblot, the bottom band of the doublet was the stronger of the cient criterion by which to de®ne a VSMC, we believe that
two. The migration position of SmaA (43 kDa) is indicated by the SMaA does provide a means of identifying presumptive
arrow. Reactions in which the SDS incubation step was omitted muscle cells, including VSMC. SMaA is expressed by em-
did not result in any reproducible immunoreactivity; if nonim- bryonic cells other than primordial VSMCs; most impor-
mune IgM was used no bands were detected (data not shown). tantly transient SMaA expression is part of the differentia-
tion program of both primordial cardiac and skeletal muscle
cells (Ruzicka and Schwartz, 1988; Sawtell and Lessard,
1989; Sugi and Lough, 1992). Given the fact that SMaA is1E12: An Early Marker for Determined VSMCs? expressed in many cell types both in vitro and in vivo, it is
striking that SMaA expression is observed in discrete areasTo explore the hypothesis that primordial VSMCs express
novel proteins as they become committed, we have pro- of the embryo, including the mesoderm surrounding the
descending aorta. However, as shown in Fig. 4b, it is notduced monoclonal antibodies directed against embryonic
vessel wall antigens. The protocols we used for generation possible to determine if the SMaA-positive cells, which are
not immediately adjacent to the endothelium and not orga-and screening of these MAbs were designed to develop a
useful marker for studies of vascular development. One of nized into a distinct vascular structure, are truly committed
to a VSMC fate. It would appear that the SMaA-positivethese MAbs, 1E12, speci®cally recognizes primordial
VSMCs in the early embryo. Observations based on immu- cells surrounding the aortic endothelium have undergone a
developmental decision that distinguishes them from thenolocalization show that expression of the 1E12 antigen is
not a component of either the cardiac or skeletal muscle remainder of the surrounding mesoderm. There is now evi-
dence that the SMaA gene promoter is regulated in a tissue-differentiation program. To the best of our knowledge, 1E12
is the only de®ned marker which is speci®c to smooth mus- speci®c manner (Shimizu et al., 1995). However, we cannot
establish whether all of the SMaA-positive cells in the re-cle cells at these early critical stages of vessel wall develop-
ment (see Fig. 1 in the review by Owens, 1995, for a listing gion of the aorta are expressing SMaA in a smooth muscle-
speci®c manner. It is not clear from our studies whetherof the onset of expression of SMC differentiation markers).
Myosin light chain kinase (MLCK) expression also has been these SMaA-positive cells surrounding the aortic endothe-
lium are truly a population of determined primordialsuggested by Duband and co-workers (1993) to be restricted
to smooth muscle cells in a 30-somite chicken embryo; VSMCs or whether SMaA expression is a component of a
mesodermal cell differentiation pathway for cells located inhowever, these data were not shown.
As de®ned by Slack (1991), commitment to a particular particular environments, with a ®nal result that some of
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these cells will continue along the path of VSMC differenti- The varied expression of the JB3 antigen is, therefore, indic-
ative of the complex differentiation program of embryonication and others will not.
vessel wall cells. Speci®c local ECM biosynthesis may be
one manifestation of VSMC heterogeneity during the earli-
Fibulin 1 and the JB3 Antigen: Potential Roles in est stages of vascular development.
Vessel Wall Development
Fibulin-1 has recently been reported to be a constituent
Does the Environment Surrounding the Descendingof the core of elastic tissue micro®brils in adult human
Dorsal Aorta Contribute to the Developmentalvessel walls (Roark et al., 1995). The process of elastogen-
Patterns Described by VSMC Markers?esis is initiated by the secretion and localization of elastin
precursors (aldehyde-rich protein and soluble tropoelastin) The unique environment surrounding the dorsal aorta in
early development provides several clues for de®ning VSMCin the aortic wall at the interface of the myocardial cuff and
out¯ow tract in stage 21±22 avian embryos (Rosenquist et lineage. From our results it appears that mesodermal cells
are not recruited to the aortic endothelium equally from allal., 1988). Elastogenesis proceeds distally from this region
along the length of the aorta by stage 28. Interestingly, the directions. We have observed that an initial population of
mesodermally derived cells associates with the endothe-aldehyde-rich protein is purported to be a micro®brillar
ECM protein (Rosenquist et al., 1988). Our data suggest that lium of the descending aorta, adjacent to the ventral surface.
We believe these cells to be primordial VSMCs. As shown®bulin-1 is expressed by presumptive VSMCs located on
the ventral surface of fusing aortae in stage 19 embryos (Fig. in Figs. 5a and 5b, SMaA-positive cells are present in a
single layer of cells located between the endoderm and en-9). This is the ®rst report of ®bulin-1 expression in the aortic
vessel wall prior to the initiation of elastogenesis. Fibulin- dothelium. This suggests a role for either one or both of
these tissues in VSMC determination. It is possible that an1 expression by primordial VSMCs may represent an early
step in the differentiation pathway of VSMCs. The expres- inductive signal is released from the ventral surface of the
endothelium or from another ventral structure, such as thesion of ®bulin-1 may be coordinately regulated with other
early markers of VSMCs, as it appears to be expressed in the endoderm. It is equally plausible that an inhibitory signal
(possibly notochordal) is present near the dorsal surface ofsame pattern as SMaA and the 1E12 antigen. Additionally,
®bulin-1 may act as a provisional matrix (or as part of a the aortic endothelium, and all surfaces of the endothelium
are equally capable of recruiting mesodermal cells in itsprovisional matrix) for the developing vessel wall and/or
may provide a template for the subsequent expression of absence.
Based on the present data, it cannot be determined whatelastin precursors in the developing vessel wall.
The JB3 antigen, a putative avian ®brillin or ®brillin-asso- role the endothelium has in VSMC determination and dif-
ferentiation, but results from this study are consistent withciated ECM protein, was initially identi®ed as a marker for
endocardial cell heterogeneity (Wunsch et al., 1995). In the a paracrine role for the endothelium. In all cases the ®rst
cells to express early VSMC markers, SMaA and 1E12, wereearly stages of vessel wall formation it is not expressed in
a ®bulin-1-like pattern, although the JB3 antigen is a consti- located immediately adjacent to the endothelium. In the
cardinal veins, shown in Fig. 2a, SMaA-positive cells aretutive element of vessel wall ECM later in development
(Bouchey et al., 1996; Wunsch et al., 1994). This is not initially located on the ventromedial surface of the endothe-
lium. The cardinal vein-associated cells face the ventralsurprising given that the composition of vessel wall ECM
varies with the differentiated state of the VSMC. Glukhova aortic environment where SMaA-positive cells are present.
It is interesting that there are no SMaA-positive cells pres-and co-workers have shown that as human aortic VSMCs
mature the repertoire of ®bronectin splice variants and lam- ent in the mesoderm between the two vessels. Therefore,
it does not appear that the SMaA-positive cells in the meso-inin chain variants the cell secretes changes (Glukhova et
al., 1989, 1990, 1993). Bouchey and co-workers (1996) ob- derm surrounding the descending aorta are a population of
VSMC precursors that ``seed'' the forming media of nearbyserve a differential expression pattern for the JB3 antigen in
elastic versus muscular vessels of older staged embryos. In vessels. These observations are most compatible with the
hypothesis that vascular endothelial cells induce the meso-elastic vessels, the JB3 antigen is associated with all of the
VSMC layers. However, in muscular vessels, such as the dermal cells in their immediate environment. Zerwes and
Risau (1987) hypothesized that endothelial cells regulatecoronary arteries, JB3 expression is associated only with the
adventitial layers and the intima (most likely the internal the character of the vascular wall, such that a chemotactic
factor (PDGF) is secreted from the basal surface of the endo-elastic lamina). The results of the present study support a
differential expression pattern for the JB3 antigen during thelium, causing migration of cells to the vessel wall. Inter-
estingly, a recent report by Shinbrot et al. (1994) demon-the initial events of vessel wall development (Fig. 10). As
reviewed by Adams and Watt (1993), regulation of ECM strates the presence of PDGF b receptors in the primordial
VSMC layers of 10.5-day embryonic mouse vessels by incomposition during development can have profound effects
on cell behavior. It is frequently proposed that developing situ hybridization. However, this hypothesis does not ad-
dress the question of whether the cells attracted to the endo-VSMCs are composed of a heterogeneous population of cells
(Nanaev et al., 1991; Cook et al., 1994; Mironov et al., 1995). thelium are already committed to the VSMC differentiation
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program or whether factors secreted from the endothelium cruitment and/or induction signals from the endothelial
cells on the aortic surfaces closest to the notochord.would also effect VSMC determination.
Alternatively, our data cannot exclude the possibility that We cannot determine from our study whether the devel-
opment of vessels other than the aorta takes place in asome VSMCs may be derived from an epithelial to mesen-
chymal transition on the part of endothelial cells. Immuno- similar manner. The use of experimental developmental
systems outside of the context of the entire embryo mayhistochemical analysis of ®bulin-1 in our laboratory (Spence
et al., 1992) and recent in situ hybridization data from help to address this issue. Studies from Krah et al. (1994),
using quail embryoid bodies, have shown that the presenceZhang et al. (1996) suggest that this ECM molecule is asso-
ciated with epithelial±mesenchymal transformations in of endoderm alone is not suf®cient for SMaA expression by
mesodermal cells and that the endothelium may play a roleother tissues such as neural tube, somite, and heart. It is
intriguing, therefore, that ®bulin-1 is expressed by SMaA- in either VSMC determination or differentiation. Results
from Saint-Jeannet and co-workers (1992), using mesodermpositive cells near the aortic endothelium. Further studies
are needed to evaluate the role of endothelial cell popula- induction assays in Xenopus embryos, suggest that not all
mesodermal tissue is capable of SMaA expression. How-tions in vessel wall development.
It is well documented in the literature that the endoderm ever, these studies are dif®cult to interpret, because the
only means used to identify cells as VSMC precursors inis a potent inducer of many mesodermal tissues (Gilbert,
1988; Jacobson and Sater, 1988; Flamme, 1989; Sugi and these studies was SMaA expression. Thus, it is not clear
whether these SMaA-positive cells are capable of continu-Lough, 1994). It is possible that an inductive event between
the endoderm and the splanchnic mesodermal cells, adja- ing along the differentiation program for VSMCs or whether
a multistep signaling mechanism is necessary.cent to the endoderm, occurs such that some of these cells
are now determined to be VSMCs. From the observation In the ®nal analysis it is critical to remember the versatil-
ity and synthetic nature of the primordial VSMC. The pri-that cells expressing SMC markers are located in the dorsal
mesentery, Duband et al. (1993) speculate that VSMC pre- mordial VSMC must coordinately regulate a repertoire of
cellular as well as extracellular matrix proteins during thecursors may arise from the splanchnic epithelium which
overlies the endoderm. It is noteworthy that in the present course of its differentiation program. The VSMC develop-
mental and maturation pattern we describe with antibodystudy we observed SMaA-positive cells localized in a thin
layer between the endoderm and endothelium in a stage 17 markers to the 1E12 antigen, SMaA, and ®bulin-1 is only
a small portion of the differentiation program of the vesselembryo (Figs. 5c and 5d) prior to the formation of a dorsal
mesentery in this region of the embryo. As development wall. The pattern described here yields several important
clues as to the origin of VSMCs. Our work and that of othersproceeds, the endoderm is drawn into the midline to form
the gut. This developmental process provides a plausible (Ruzicka and Schwartz, 1988) suggest that VSMCs differen-
tiate from the mesoderm in local environments rich in po-explanation for observing SMaA-positive cells located at
the midline in later stage embryos (Fig. 6c). That is, SMaA- tential inducing molecules. The area ventral to the aortic
endothelium appears to be one of these areas.positive cells, which had been located along the length of
the endoderm, would be drawn toward the axial region,
ventral to the aorta, and dorsal to the newly formed diges-
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